June 5, 2017 – The U.S. Food and Drug Administration (FDA) granted market clearance for the Claret Medical Sentinel Cerebral Protection System (CPS), via de novo classification, enabling U.S.
Embolic Protection Devices
-
-
Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage due to emboli released during the procedure.
-
October 14, 2015 — Claret Medical, an innovator in cardiovascular cerebral protection, Data presented this week at Transcatheter Cardiovascular Therapeutics (TCT) 2015 showed the first definitive...
-
September 22, 2014 — A first-of-its kind study found that using a cerebral protection device during transcatheter aortic valve replacement (TAVR) can significantly reduce the number and volume of...
Feature | Heart Valve Technology | June 09, 2017
June 5, 2017 – The U.S. Food and Drug Administration (FDA) granted market clearance for the Claret Medical Sentinel ...
News | Peripheral Arterial Disease (PAD) | May 17, 2017
May 17, 2017 — Contego Medical LLC announced recently that it has received CE Marking of its Vanguard IEP Peripheral...
News | Embolic Protection Devices | April 11, 2017
April 11, 2017 — Through a new clinical trial, patients at Harrisburg, Pa.-based PinnacleHealth have access to an...
The CardioGard embolic protection system for surgical aortic valve replacement.
Feature | Embolic Protection Devices | March 22, 2017
March 22, 2017 — Two U.S. Food and Drug Administration (FDA)-cleared embolic protection systems designed to remove...
News | Heart Valve Technology | February 28, 2017
February 28, 2017 — A U.S. Food and Drug Administration (FDA) panel has recommended market clearance for the Claret...
News | Stents Carotid | November 18, 2016
November 18, 2016 — InspireMD Inc. announced in mid-October the online publication of positive clinical data in a...
Videos | Heart Valve Technology | November 08, 2016
Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage...
News | Heart Valve Technology | November 07, 2016
November 7, 2016 — Keystone Heart Ltd. announced that data presented at the Transcatheter Cardiovascular...
News | Heart Valve Technology | November 07, 2016
November 7, 2016 – A multicenter randomized trial evaluating the role of embolic protection using the Sentinel...
News | Embolic Protection Devices | September 29, 2016
September 29, 2016 — Keystone Heart Ltd. recently announced the safety and efficacy of the TriGuard Cerebral...
News | Embolic Protection Devices | September 20, 2016
September 20, 2016 – Claret Medical announced its filing of a marketing application with the U.S. Food and Drug...
The Boston Scientific Watchman device is currently the only transcatheter LAA occluder cleared for use in the United States.
Feature | Left Atrial Appendage (LAA) Occluders | May 20, 2016 | Dave Fornell
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater...
The Claret TAVR embolic protection system as seen in the aortic arch under angiography. The loops contain embolic filters they protect the ostium of vessles leading to the brain.
Feature | Heart Valve Technology | October 16, 2015
October 14, 2015 — Claret Medical, an innovator in cardiovascular cerebral protection, Data presented this week at...
Image courtesy of InspireMD
News | Embolic Protection Devices | June 23, 2015
June 23, 2015 - InspireMD Inc. announced that its CGuard...
Technology | June 01, 2015
June 1, 2015 — Silk Road Medical Inc. announced the company received U.S. Food & Drug Administration (FDA) 510(k...
